| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 24,580 | 24,760 | 12.06. | |
| 24,560 | 24,720 | 12.06. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 30,000 | 25 | |||
| 26,840 | 2.040 | |||
| 26,400 | 2.040 | |||
| 25,960 | 2.040 | |||
| 25,040 | 248 | |||
| 24,920 | 18 | |||
| 24,880 | 18 | |||
| 24,840 | 18 | |||
| 24,740 | 790 | |||
| 24,700 | 248 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/bv3.htm [/URL] | ||||
| 790 | 24,580 | |||
| 248 | 24,520 | |||
| 18 | 24,440 | |||
| 18 | 24,400 | |||
| 18 | 24,360 | |||
| 248 | 24,240 | |||
| 2.040 | 24,080 | |||
| 2.040 | 23,320 | |||
| 2.040 | 22,880 | |||
| 2.040 | 22,440 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 9.500 | 0,788 | 7.485 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 13:23:07 | 24,760 | 40 |
| Tagesumsatz Xetra | +0,300 +1,23 % | 62 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BAVARIAN NORDIC Aktie jetzt für 0€ handeln | |||||
| Mi | Bavarian Nordic: Regierung greift zu - die Details | 355 | Der Aktionär | Lange war es recht ruhig um den Impfstoffspezialisten Bavarian Nordic. In dieser Woche konnte das Unternehmen jedoch für positive News sorgen. Zuvor griff das vom AKTIONÄR platzierte Abstauberlimit... ► Artikel lesen | |
| Di | Bavarian Nordic Wins DKK 700 Million Smallpox/Mpox Vaccine Supply Contract | 15 | RTTNews | ||
| Di | Bavarian Nordic sichert sich Impfstoff-Auftrag über 700 Millionen DKK | 19 | Investing.com Deutsch | ||
| Di | Bavarian Nordic wins DKK 700 million vaccine contract | 5 | Investing.com | ||
| Di | Bavarian Nordic A/S: Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine | 398 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, June 9, 2026 - Bavarian Nordic A/S (OMX: BAVA) today announced the award of a government contract valued over DKK 700 million to supply its MVA-BN smallpox/mpox vaccine to an undisclosed... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Do | Xbrane Biopharma AB: Xbrane Biopharma AB and JOINN Biologics US Inc. Enter Strategic Partnership to Develop Xdarzane - Xbrane's Biosimilar Candidate to Darzalex (Daratumumab) | GlobeNewswire (Europe) | Solna, Sweden and Richmond, CA, US - Xbrane Biopharma AB ("Xbrane"), a Sweden-based biotechnology company focused on the development of biosimilars, and JOINN Biologics US Inc. ("JOINN"), a US-based... ► Artikel lesen | |
| Fr | Weekly Buzz: Guardant Health, Eli Lilly Gain FDA Nod; Teva Pharmaceutical, GSK, Lead M&A Wave; Zealand Pharma, Eli Lilly Post Strong Data | AFX News | NEW BRUNSWICK (dpa-AFX) - This week, the biotech sector saw a surge of FDA, EU, and China approvals spanning oncology, dermatology, autoimmune and rare disease indications. Strategic acquisitions... ► Artikel lesen | |
| Fr | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 12.06.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 12.06.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 12.06.2026.ISIN NameAU0000154148 HARTSHEAD... ► Artikel lesen | |
| Fr | EQS Newswire: CStone Pharmaceuticals: CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights | EQS Group (EN) | EQS Newswire / 12/06/2026 / 15:02 UTC+8
Shanghai - 12 Jun 2026 - The clinical datasets presented at ASCO 2026 further validate the trispecific synergistic mechanism of CS2009 and support its potential... ► Artikel lesen | |
| Fr | BioNxt Solutions Inc.: BioNxt Announces Non-Brokered Private Placement of Units Pursuant to the Listed Issuer Exemption | ACCESS Newswire | Not for distribution to U.S. newswire services or for dissemination in the United States. VANCOUVER, BC / ACCESS Newswire / June 12, 2026 / BioNxt Solutions Inc. (CSE:BNXT)(FSE:4XT) (the "Company" or... ► Artikel lesen |